Piston Bio

Executive Summary

Piston Bio is a San Diego-based biotechnology company founded in 2021, focused on developing novel protein engineering platforms for advanced biologics, particularly engineered cytokines targeting oncology and immunology. The company aims to leverage its proprietary technology to create next-generation therapeutics with improved efficacy and safety profiles. As a preclinical-stage private company, Piston Bio has not yet disclosed specific pipeline candidates or funding details, positioning it as an early-stage player in the competitive biologics space. Its success hinges on platform validation through preclinical data and subsequent financing to advance lead programs toward the clinic. Given the limited public information, the company represents a high-risk, high-reward opportunity, with potential differentiation in cytokine engineering that could address key limitations of current immunotherapies.

Upcoming Catalysts (preview)

• TBDSeries A or Seed Extension Financing40% success
• TBDLead Candidate Nomination50% success
• TBDIn Vivo Proof-of-Concept Data Release45% success